EU Agency Confirms Suspension of Merck Cholesterol Drug

Europe’s drug regulator has confirmed it is suspending marketing authorizations for Merck’s cholesterol drug Tredaptive (niacin/laropiprant) in Europe after its failure in a major study raised safety concerns.
Reuters